All News

Gene expression may lead to castration-resistant prostate cancer.

Patients may be less likely to undergo a blood test to diagnose HIV.

A multiple sclerosis drug may be used as a PET scan tracer agent to image demyelination.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Patients with both hepatitis C and type 2 diabetes can develop fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment.

Patients with Parkinson disease who have a specific genetic mutation show a slower decline in motor functioning compared to patients without the mutation.

When frontline pharmacists are trained to provide travel health services, they can expand access to patients due to their convenience.

Vector-based gene therapy shows efficacy treating glaucoma.

Sen Bill Cassidy, MD (R-LA), proposes legislation that would require hospitals to pass 340B savings on to patients.

Court invalidates patent for abiraterone acetate (Zytiga).

Limited access to gene therapies may impact Americans with rare cancers who live in rural areas.

Inhibiting a specific protein reduces the clinical characteristics of atomic dermatitis.

Officials with the FDA have issued 2 final guidance documents to help implement the 2018 Compounding Policy Priorities Plan, which explain the agency’s policies on the “essentially a copy” provisions of sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Significant progress has been made with field of gene therapy over the past few decades.

High-grade cardiovascular adverse events are twice as common when patients with multiple myeloma are treated with carfilzomib.

Controlling cholesterol synthesis expression may reduce walking disability in patients with multiple sclerosis.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Novel HIV test combines the convenience of the saliva test with the reliability of the blood test.

CAM2038 would have been the first and only injectable for opioid use disorder that can be administered by health care professionals from the start of a patient's treatment.

.We look at both sides of the debate when a manager tells the pharmacist to clean the bathroom.

Participants in the Transform Rheumatoid Arthritis Care program could save 5% on drug spend.

Greater use of substituting generic drugs could have a major impact on Medicare Part D spending.

Chronochemotherapy plus an p38 MAPK inhibitor may reduce the aggressiveness of glioblastoma cells.

CRSPR-Cas9 technology observed to increase lifespan in mice models of ALS.

Three genes may increase the risk of breast and ovarian cancers in patients with BRCA mutations.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.